Genclis

Genclis is a biotechnology company focused on developing therapies for both human and animal health using Transcription Infidelity (TI). It commercializes pre-clinical and cellular models in allergy and autoimmunity to evaluate therapeutic, probiotic, and nutritional solutions. The company also manufactures and markets reagents for diagnostic and preclinical use.